Navigation Links


Hypertension at medicine products

ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK4 Angiotensin Converting Enzyme

Description:Angiotensin Converting Enzyme (ACE) is an integral part of the enzymatic cascade leading to the generation of Angiotensin II as well as the degradation of Bradykinin. Found in many different cell types, ACE is primarily located in endothelial cells. ACE is not only an important diagnostic parameter for sarcoidosis and myocardial infarction but is also an important parameter for determining genera...
Company:ALPCO Diagnostics

ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK Angiotensin Converting Enzyme

Description:Angiotensin Converting Enzyme (ACE) is an integral part of the enzymatic cascade leading to the generation of Angiotensin II as well as the degradation of Bradykinin. Found in many different cell types, ACE is primarily located in endothelial cells. ACE is not only an important diagnostic parameter for sarcoidosis and myocardial infarction but is also an important parameter for determining genera...
Company:ALPCO Diagnostics

ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACKX Angiotensin Converting Enzyme

Description:Angiotensin Converting Enzyme (ACE) is an integral part of the enzymatic cascade leading to the generation of Angiotensin II as well as the degradation of Bradykinin. Found in many different cell types, ACE is primarily located in endothelial cells. ACE is not only an important diagnostic parameter for sarcoidosis and myocardial infarction but is also an important parameter for determining genera...
Company:ALPCO Diagnostics

ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018

Description:ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Company:ALPCO Diagnostics

Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105

Description:Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105...
Company:ALPCO Diagnostics

Angiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22

Description:Angiotensin II (Ang II) is the most potent pressure agent known to date and is the biologically active peptide of the renin-angiotensin system (RAS). The proteolytic enzyme renin, synthesized, stored and secreted primarily by the juxtaglomerular cells of the kidneys, cleaves angiotensinogen to produce the decapeptide angiotensin I (Ang I) which is physiologically inactive. Ang I is rapidly cle...
Company:ALPCO Diagnostics

Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones

Description:The test kit is an enzyme immunometric assay (EIA) in the microplate format with a liquid phaseincubation, designed for the quantitative measurement of cortisol in serum. The microplate is coatedwith anti-rabbit antibodies.Calibrators and patient samples are added to anti-rabbit antibody-coated wells, along with rabbit anticortisolantibodies and ligand-labeled cortisol. During the 60-...
Company:ALPCO Diagnostics

ACE - REA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-ACD Angiotensin Converting Enzyme

Description:Angiotensin Converting Enzyme (ACE), also known as Kininase II, is a dipeptidyl carboxypeptidase (EC 3.4.15.1) with a molecular weight of at least 129,000. The structure of this glycoprotein shows a single polypeptide chain, a polysaccharide residue and a zinc atom. ACE is present in many different cell types such as neuronal cells and renal proximal tubular cells, but is mostly found in endothel...
Company:ALPCO Diagnostics

Lyphochek Hypertension Markers Control

Description:Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders....
Company:Bio-Rad Laboratories

Cochrane Reviews in Hypertension

Description:Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source available for continually updated evidence-based medical information. Each review explores the evid...
Company:Skyscape, Inc.
Other TagsWorkersWorkersWorkersLohanSurfaceSurfaceSurfaceSurfaceSurface
(Date:10/9/2008)...e years, the number of patients with compromised i...patients such as these require a unique set of hea...rything from the etiology and degree of immune sup...tatus. A new text from ASM Press, Diagnostic Micro... wide range of approaches and challenges to infect...
(Date:10/9/2008)...a major role in anencephaly, offering hope for a g...th defect in which the brain fails to develop, acc...ty of Illinois at Chicago College of Medicine. , ...rnal of Molecular Endocrinology . , In the U.S...ly each year. Most do not survive more than a day ...
(Date:10/9/2008)...f Allergy and Infectious Diseases (NIAID), part of...rd five-year contracts estimated to be up to $68.7...for Infectious Disease Research at four research i...y novel techniques to study diseases that include ...osis and influenza. , Systems biology is the stu...
(Date:10/9/2008)...th, 2008 The United States lacks the policies need...ll not cause environmental harm, says a distinguis...published in the October 3rd issue of the journal ...s and incentives that will help ensure that future...cally and environmentally. , Because the cellulo...
Breaking Biology News(10 mins):Text focuses on diagnosing infections in immunocompromised patients 2Clue to genetic cause of fatal birth defect 2New Systems Biology Awards enable detailed study of microbes 2Experts agree: to protect the environment, biofuel standards are needed 2Guava Technologies Celebrates Tenth Anniversary 3052 1Guava Technologies Celebrates Tenth Anniversary 3052 2Fertilizer research center an Australian first 2131 1Fertilizer research center an Australian first 2131 2BioSpecifics Technologies Corp Announces Repayment of Outstanding Loan 3050 1Anadys Pharmaceuticals to Present at the BIO CEO 26 Investor Conference 3048 1Anadys Pharmaceuticals to Present at the BIO CEO 26 Investor Conference 3048 2
(Date:10/10/2008)... Topics range from bullying to incorporating PD...Vocus) October 10, 2008 -- Several pediatric exper...be presenting at the 2008 American Academy of Pedi...uns from October 11 - 14 in Boston. Presenters and...Best, MD, MPH, will present "Promoting Smoke-...
(Date:10/10/2008)...k Teams Up with Legal and Medical Panel to Offer,R...reers Seminar in,Knoxville, KNOXVILLE, Tenn., Oct...east Cancer Awareness Month, Cancer and Careers an...th YWCA Knoxville, The Wellness Community-East,Ten...niversity of Tennessee,women,s basketball associat...
(Date:10/10/2008)... Honoring excellence in the implementation of e...formation and Management Systems Society (HIMSS) a...in the Organizational, Ambulatory and Community He... Chicago, IL (PRWEB) October 10, 2008 -- Hon...ic health records (EHRs), the Healthcare Informat...
(Date:10/10/2008)... Oct. 10 /PRNewswire-FirstCall/ -- Accuray,Incorpo...ld of radiosurgery,today announced that it will r...09, ending September 27, 2008, on Wednesday, Octob...e call to review the results will begin at 2:00 p....S. Thomson, Ph.D., president and,chief executive o...
Breaking Medicine News(10 mins):Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2
Other Contentshypoplastichypospadiashypospadiashypoparathyroidismhypopituitarismhypotensionhypotensionhyposensitizationhypothalamichypothalamichypothalamichypothalamichypothermiahypothermiahypothermia